Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Jonathan Terdiman, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1701 Divisadero St
    San Francisco CA 94115
    Phone415-502-4444
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Columbia UniversityM.D.School of Medicine1989
      University of California, San FranciscoResidency Internal Medicine1992
      University of California, San FranciscoFellowshipCritical Care Medicine1993
      University of California, San FranciscoFellowshipGastroenterology1996

      Collapse Overview 
      Collapse Overview
      Dr. Jonathan P. Terdiman is a Professor of Clinical Medicine and Surgery at UCSF. He earned his undergraduate degree from Princeton University in 1985 and his medical degree from the Columbia University College of Physicians and Surgeons in 1989. Dr. Terdiman completed his internal medicine residency and fellowships in both critical care medicine and gastroenterology at UCSF before joining the faculty in 1996. Dr. Terdiman currently serves as the Director of the Adult Gastroenterology Service, the Program Director of the Gastroenterology Fellowship Training Program, and Director of the Gastrointestinal Cancer Prevention Program at UCSF. Dr. Terdiman has been the recipient of numerous school-wide teaching awards and in 2013 Dr Terdiman was elected to the Department of Medicine’s Master Clinician Council. This is a rare and distinct honor and a testament to the high esteem in which Dr. Terdiman is held by his colleagues. Dr. Terdiman is considered by his peers and the community to be one of the leading practitioners of gastroenterology in the Bay area, and he serves as an invaluable resource to patients and referring providers alike. Dr. Terdiman has a reputation among his peers for taking on the most challenging cases and for his attention to detail and compassion.

      Dr. Terdiman’s primary clinical and research activities are focused on the treatment of patients at high risk for gastrointestinal cancer and those with inflammatory bowel disease, though he cares for patients with a wide range of gastrointestinal diseases. He is engaged in research projects regarding how to assess and mitigate the risk of cancer among patients and families with a genetic predisposition to the disease. He also is actively engaged in projects assessing the safety and efficacy of new drugs in the treatment of inflammatory bowel disease, and recently he and his colleagues have embarked on an exciting series of studies examining the role of the microbiome in the etiology of IBD. The goal of these latter studies is to understand if manipulation of the microbiome be an important form of therapy for patients with IBD. Initial studies are focusing on the use of diet and fecal transfer to achieve these goals.

      Dr Terdiman has served on the board of the Northern California Chapter of the Crohn’s and Colitis Foundation of America (CCFA) for many years, and was board president from 2010-2012. In 2012 the chapter named Dr. Terdiman as a CCFA Champion of Hope. Dr. Terdiman also is the lead author of the American Gastroenterological Association guidelines regarding the proper use of immune modulators and biological drugs in the treatment of Crohn’s disease. Dr. Terdiman is a past associate editor of the American Journal of Gastroenterology and he is a fellow of the American College of Gastroenterology and American College of Physicians.


      Collapse ORNG Applications 
      Collapse Websites
      Collapse Clinical Trials
      Collapse Global Health

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Azofra AS, Kidambi TD, Jeremy RJ, Conrad P, Blanco A, Myers M, Barkovich J, Terdiman JP. Differences in neuropsychological and behavioral parameters and brain structure in patients with familial adenomatous polyposis: a sibling-paired study. Hered Cancer Clin Pract. 2016; 14:20. PMID: 27777639.
        View in: PubMed
      2. Kidambi TD, Lee R, Terdiman JP, Day L, et al. Successful implementation of Lynch syndrome screening in a safety net institution. J Community Genet. 2016 Jul 2. PMID: 27372833.
        View in: PubMed
      3. Kidambi TD, Blanco A, Van Ziffle J, Terdiman JP. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome. Fam Cancer. 2016 Apr; 15(2):275-80. PMID: 26781822.
        View in: PubMed
      4. Guindalini RS, Win AK, Gulden C, Lindor NM, Newcomb PA, Haile RW, Raymond V, Stoffel E, Hall M, Llor X, Ukaegbu CI, Solomon I, Weitzel J, Kalady M, Blanco A, Terdiman J, Shuttlesworth GA, Lynch PM, Hampel H, Lynch HT, Jenkins MA, Olopade OI, Kupfer SS. Mutation Spectrum and Risk of Colorectal Cancer in African American Families with Lynch Syndrome. Gastroenterology. 2015 Nov; 149(6):1446-53. PMID: 26248088; PMCID: PMC4648287 [Available on 11/01/16].
      5. Goodenberger ML, Thomas BC, Riegert-Johnson D, Boland CR, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK, Macrae FA, Lynch HT, Weitzel JN, de la Chapelle A, Syngal S, Lynch P, Parry S, Jenkins MA, Gallinger S, Holter S, Aronson M, Newcomb PA, Burnett T, Le Marchand L, Pichurin P, Hampel H, Terdiman JP, Lu KH, Thibodeau S, Lindor NM. PMS2 monoallelic mutation carriers: the known unknown. Genet Med. 2016 Jan; 18(1):13-9. PMID: 25856668.
        View in: PubMed
      6. Kidambi TD, Terdiman JP. Screening for Lynch syndrome: it is time to shift the focus. Dig Dis Sci. 2015 Feb; 60(2):586-7. PMID: 25563721.
        View in: PubMed
      7. Lee JK, Terdiman JP, Corley DA. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Jul 10; 371(2):186. PMID: 25006739.
        View in: PubMed
      8. Kidambi TD, Blanco A, Myers M, Conrad P, Loranger K, Terdiman JP. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience. Dig Dis Sci. 2015 Aug; 60(8):2463-9. PMID: 24903654.
        View in: PubMed
      9. Walsh JM, Potter MB, Arora M, Gildegorin G, Terdiman J. A workplace colorectal cancer screening program in firefighters: lessons learned. Occup Med (Lond). 2014 Jun; 64(4):255-8. PMID: 24744344.
        View in: PubMed
      10. Shah S, Terdiman J, Gundling K, Mahadevan U. Immunoglobulin therapy for refractory Crohn's disease. Therap Adv Gastroenterol. 2014 Mar; 7(2):99-102. PMID: 24587823; PMCID: PMC3903086.
      11. Terdiman JP, Gruss CB, Heidelbaugh JJ, Sultan S, Falck-Ytter YT. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013 Dec; 145(6):1459-63. PMID: 24267474.
        View in: PubMed
      12. Truta B, Li DX, Mahadevan U, Fisher ER, Chen YY, Grace K, Velayos F, Terdiman JP. Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis. Dig Dis Sci. 2014 Jan; 59(1):135-45. PMID: 24091907.
        View in: PubMed
      13. Yurgelun MB, Mercado R, Rosenblatt M, Dandapani M, Kohlmann W, Conrad P, Blanco A, Shannon KM, Chung DC, Terdiman J, Gruber SB, Garber JE, Syngal S, Stoffel EM. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol. 2012 Dec; 127(3):544-51. PMID: 22940489; PMCID: PMC3496001.
      14. Kuppermann M, Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U. Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. Cancer. 2013 Jan 1; 119(1):215-25. PMID: 22786716; PMCID: PMC4356667.
      15. Katz L, Gisbert JP, Manoogian B, Lin K, Steenholdt C, Mantzaris GJ, Atreja A, Ron Y, Swaminath A, Shah S, Hart A, Lakatos PL, Ellul P, Israeli E, Svendsen MN, van der Woude CJ, Katsanos KH, Yun L, Tsianos EV, Nathan T, Abreu M, Dotan I, Lashner B, Brynskov J, Terdiman JP, Higgins PD, Chaparro M, Ben-Horin S. Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis. 2012 Nov; 18(11):2026-33. PMID: 22294554.
        View in: PubMed
      16. Larsen M, Hills N, Terdiman J. The impact of the quality of colon preparation on follow-up colonoscopy recommendations. Am J Gastroenterol. 2011 Dec; 106(12):2058-62. PMID: 22138933.
        View in: PubMed
      17. Lin KK, Velayos F, Fisher E, Terdiman JP. Durability of infliximab dose intensification in Crohn's disease. Dig Dis Sci. 2012 Apr; 57(4):1013-9. PMID: 22089254.
        View in: PubMed
      18. Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011 Jul 19; 155(2):69-79. PMID: 21768580; PMCID: PMC3793257.
      19. Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J. Performance of Lynch syndrome predictive models in a multi-center US referral population. Am J Gastroenterol. 2011 Oct; 106(10):1822-7; quiz 1828. PMID: 21747416; PMCID: PMC3804147.
      20. Terdiman JP. The prevention of colitis-related cancer by 5-aminosalicylates: an appealing hypothesis that remains unproven. Am J Gastroenterol. 2011 Apr; 106(4):737-40. PMID: 21468069.
        View in: PubMed
      21. Day LW, Espey DK, Madden E, Segal M, Terdiman JP. Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan natives in the Indian Health Service. Dig Dis Sci. 2011 Jul; 56(7):2104-13. PMID: 21234688; PMCID: PMC3112488.
      22. Terdiman JP, McQuaid KR. Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastroenterology. 2010 Nov; 139(5):1444-7. PMID: 20875785.
        View in: PubMed
      23. El-Nachef N, Terdiman J, Mahadevan U. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. Am J Gastroenterol. 2010 May; 105(5):1210-1. PMID: 20445523.
        View in: PubMed
      24. Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol. 2010 Aug; 105(8):1851-60. PMID: 20354509; PMCID: PMC3091484.
      25. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton SR, Ismail MK, Jasperson K, Lazenby AJ, Lynch PM, Martin EW, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw. 2010 Jan; 8(1):8-61. PMID: 20064289.
        View in: PubMed
      26. Terdiman JP, Johnson LK, Kim YS, Sleisenger MH, Gum JR, Hayes A, Weinberg VK, McQuaid KR. Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study. Dig Dis Sci. 2009 Nov; 54(11):2488-96. PMID: 19757048; PMCID: PMC2762046.
      27. Terdiman JP. MYH-associated disease: attenuated adenomatous polyposis of the colon is only part of the story. Gastroenterology. 2009 Dec; 137(6):1883-6. PMID: 19879216.
        View in: PubMed
      28. Grover S, Stoffel EM, Mercado RC, Ford BM, Kohlman WK, Shannon KM, Conrad PG, Blanco AM, Terdiman JP, Gruber SB, Chung DC, Syngal S. Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol. 2009 Aug 20; 27(24):3981-6. PMID: 19620492; PMCID: PMC2734398.
      29. Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Jun; 7(6):676-81.e1-3. PMID: 19514116.
        View in: PubMed
      30. Wang JY, Terdiman JP, Vittinghoff E, Minichiello T, Varma MG. Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events. World J Gastroenterol. 2009 Feb 28; 15(8):927-35. PMID: 19248191; PMCID: PMC2653404.
      31. Li D, Jin C, McCulloch C, Kakar S, Berger BM, Imperiale TF, Terdiman JP. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009 Mar; 104(3):695-702. PMID: 19223889.
        View in: PubMed
      32. Shergill AK, Terdiman JP. The early use of immunosuppression reduces morbidity in patients with moderately severe or severe Crohn's disease. Gastroenterology. 2008 Oct; 135(4):1417-20. PMID: 18773903.
        View in: PubMed
      33. Terdiman JP. Oncology training for the gastroenterologist: a test-case for subspecialization in gastroenterology? Gastroenterology. 2008 Oct; 135(4):1028-31. PMID: 18775428.
        View in: PubMed
      34. Li D, Terdiman JP. "Did you check my colon for flat polyps?" Should patients and colonoscopists really be concerned? Gastroenterology. 2008 Jul; 135(1):315-7. PMID: 18541152.
        View in: PubMed
      35. Shergill AK, Terdiman JP. Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach. World J Gastroenterol. 2008 May 7; 14(17):2670-7. PMID: 18461652; PMCID: PMC2709053.
      36. Truta B, Chen YY, Blanco AM, Deng G, Conrad PG, Kim YH, Park ET, Kakar S, Kim YS, Velayos F, Sleisenger MH, Terdiman JP. Tumor histology helps to identify Lynch syndrome among colorectal cancer patients. Fam Cancer. 2008; 7(3):267-74. PMID: 18283560.
        View in: PubMed
      37. Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, Terdiman J, Chung DC, Syngal S. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol. 2008 Mar; 6(3):333-8. PMID: 18258490; PMCID: PMC2536607.
      38. Terdiman JP. Hereditary diffuse gastric cancer: surveillance endoscopy is not enough to save lives. Gastroenterology. 2007 Nov; 133(5):1730-2; discussion 1732-3. PMID: 17983818.
        View in: PubMed
      39. Terdiman JP. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol. 2008 Jun; 6(6):616-20. PMID: 17967564.
        View in: PubMed
      40. Shergill AK, Terdiman JP. Refining colorectal cancer screening recommendations based on gender. Gastroenterology. 2007 Jun; 132(7):2605-6. PMID: 17570233.
        View in: PubMed
      41. Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr; 13(4):367-71. PMID: 17206695.
        View in: PubMed
      42. Shergill AK, Terdiman JP. Screening colonoscopy: the benefits are durable, but are they as great as we thought? Gastroenterology. 2006 Dec; 131(6):2016-8; discussion 2018. PMID: 17188965.
        View in: PubMed
      43. Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, Kakar S, Fridlyand J, Snijders AM, Albertson DG, Thibodeau SN, Waldman FM. Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res. 2006 Nov 1; 12(21):6379-85. PMID: 17085649.
        View in: PubMed
      44. Terdiman JP. Ulcerative colitis patients with dysplastic polyps should be advised to undergo colectomy. Inflamm Bowel Dis. 2006 Sep; 12(9):916-8. PMID: 16954810.
        View in: PubMed
      45. Yang K, Allen B, Conrad P, Powell CB, Terdiman J, Chen LM. Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families. Fam Cancer. 2006; 5(4):405-9. PMID: 16937235.
        View in: PubMed
      46. Inadomi JM, Terdiman J. Exploring utilities and outcomes with infliximab therapy. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):976-8. PMID: 16880119.
        View in: PubMed
      47. Deng G, Nguyen A, Tanaka H, Matsuzaki K, Bell I, Mehta KR, Terdiman JP, Waldman FM, Kakar S, Gum J, Crawley S, Sleisenger MH, Kim YS. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int J Cancer. 2006 Jun 15; 118(12):2999-3005. PMID: 16425274.
        View in: PubMed
      48. Terdiman JP. Embarrassment is a major barrier to colon cancer prevention, especially among women: a call to action. Gastroenterology. 2006 Apr; 130(4):1364-5. PMID: 16618431.
        View in: PubMed
      49. Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW, Mayer RJ, Pasche B, Pirruccello SJ, Rajput A, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Winawer SJ. Colorectal Cancer Screening Clinical Practice Guidelines. J Natl Compr Canc Netw. 2006 Apr; 4(4):384-420. PMID: 16569391.
        View in: PubMed
      50. Walsh JM, Salazar R, Terdiman JP, Gildengorin G, Pérez-Stable EJ. Promoting use of colorectal cancer screening tests. Can we change physician behavior? J Gen Intern Med. 2005 Dec; 20(12):1097-101. PMID: 16423097; PMCID: PMC1490293.
      51. Terdiman JP. Colonoscopy is superior to flexible sigmoidoscopy for colorectal cancer screening: now beyond a reasonable doubt? Gastroenterology. 2005 Nov; 129(5):1793-4. PMID: 16285977.
        View in: PubMed
      52. Terdiman JP. It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterology. 2005 Aug; 129(2):741-4. PMID: 16083727.
        View in: PubMed
      53. Young Y, Terdiman JP. Endoscopic management of familial colonic neoplasia. Gastrointest Endosc Clin N Am. 2005 Jul; 15(3):549-80, ix-x. PMID: 15990057.
        View in: PubMed
      54. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005 Jun; 100(6):1345-53. PMID: 15929768.
        View in: PubMed
      55. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut. 2005 Jun; 54(6):890. PMID: 15888806; PMCID: PMC1774554.
      56. Velayos FS, Allen BA, Conrad PG, Gum J, Kakar S, Chung DC, Truta B, Sleisenger MH, Kim YS, Terdiman JP. Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines. Am J Gastroenterol. 2005 May; 100(5):1143-9. PMID: 15842591.
        View in: PubMed
      57. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85. PMID: 15855431; PMCID: PMC2933042.
      58. Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis. 2005 Apr; 11(4):395-9. PMID: 15803031.
        View in: PubMed
      59. Terdiman JP. Colorectal cancer at a young age. Gastroenterology. 2005 Apr; 128(4):1067-76. PMID: 15825087.
        View in: PubMed
      60. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2005 Mar 15; 21(6):733-8. PMID: 15771759.
        View in: PubMed
      61. Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74. PMID: 15738026.
        View in: PubMed
      62. Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM. Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer. Clin Cancer Res. 2005 Mar 1; 11(5):1791-7. PMID: 15756001.
        View in: PubMed
      63. Velayos FS, Lee SH, Qiu H, Dykes S, Yiu R, Terdiman JP, Garcia-Aguilar J. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer. J Gastrointest Surg. 2005 Mar; 9(3):329-35. PMID: 15749592.
        View in: PubMed
      64. Truta B, Allen BA, Conrad PG, Weinberg V, Miller GA, Pomponio R, Lipton LR, Guerra G, Tomlinson IP, Sleisenger MH, Kim YS, Terdiman JP. A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history. Fam Cancer. 2005; 4(2):127-33. PMID: 15951963.
        View in: PubMed
      65. Velayos FS, Williamson A, Sousa KH, Lung E, Bostrom A, Weber EJ, Ostroff JW, Terdiman JP. Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study. Clin Gastroenterol Hepatol. 2004 Jun; 2(6):485-90. PMID: 15181617.
        View in: PubMed
      66. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A, Wiencke JW, Terdiman JP, Waldman FM. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis. 2004 Aug; 25(8):1345-57. PMID: 15001537.
        View in: PubMed
      67. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18; 96(4):261-8. PMID: 14970275; PMCID: PMC2933058.
      68. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004 Jan 1; 10(1 Pt 1):191-5. PMID: 14734469.
        View in: PubMed
      69. Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003 Nov; 9(6):351-5. PMID: 14671483.
        View in: PubMed
      70. Hiramoto JS, Terdiman JP, Norton JA. Evidence-based analysis: postoperative gastric bleeding: etiology and prevention. Surg Oncol. 2003 Jul; 12(1):9-19. PMID: 12689666.
        View in: PubMed
      71. Terdiman JP. Aspirin curbs colon polyps. But for many, bleeding risks may offset benefits. Health News. 2003 May; 9(5):1-2. PMID: 12739451.
        View in: PubMed
      72. Allen BA, Terdiman JP. Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer. Best Pract Res Clin Gastroenterol. 2003 Apr; 17(2):237-58. PMID: 12676117.
        View in: PubMed
      73. Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003 Mar 12; 289(10):1288-96. PMID: 12633191.
        View in: PubMed
      74. Walsh JM, Terdiman JP. Colorectal cancer screening: clinical applications. JAMA. 2003 Mar 12; 289(10):1297-302. PMID: 12633192.
        View in: PubMed
      75. Truta B, Allen BA, Conrad PG, Kim YS, Berk T, Gallinger S, Bapat B, Terdiman JP, Sleisenger MH. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer. 2003; 2(2):95-9. PMID: 14574158.
        View in: PubMed
      76. Reyes CM, Allen BA, Terdiman JP, Wilson LS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer. 2002 Nov 1; 95(9):1848-56. PMID: 12404277.
        View in: PubMed
      77. Terdiman JP, Aust DE, Chang CG, Willenbucher RF, Baretton GB, Waldman FM. High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer. Cancer Genet Cytogenet. 2002 Jul 15; 136(2):129-37. PMID: 12237237.
        View in: PubMed
      78. Terdiman JP, Levin TR, Allen BA, Gum JR, Fishbach A, Conrad PG, Miller GA, Weinberg V, Bachman R, Bergoffen J, Stembridge A, Toribara NW, Sleisenger MH, Kim YS. Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology. 2002 Apr; 122(4):940-7. PMID: 11910346.
        View in: PubMed
      79. Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro-Clark A, Baretton GB, Loehrs U, Waldman FM. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer. 2002 Mar 1; 94(5):1421-7. PMID: 11920497.
        View in: PubMed
      80. Deng G, Peng E, Gum J, Terdiman J, Sleisenger M, Kim YS. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer. Br J Cancer. 2002 Feb 12; 86(4):574-9. PMID: 11870540; PMCID: PMC2375277.
      81. Terdiman JP. HNPCC: an uncommon but important diagnosis. Gastroenterology. 2001 Oct; 121(4):1005-8. PMID: 11606514.
        View in: PubMed
      82. Terdiman J, Gum Jr J, Conrad P, Miller G, Weinberg V, Crawley S, Levin T, Reeves C, Schmitt A, Hepburn M, Sleisenger M, Kim Y. [Search for microsatellite instability in colorectal cancer: an effective way to detect HNPCC?]. Gastroenterol Clin Biol. 2001 Oct; 25(10):929-31. PMID: 11852407.
        View in: PubMed
      83. Terdiman JP. Colonoscopic management of lower gastrointestinal hemorrhage. Curr Gastroenterol Rep. 2001 Oct; 3(5):425-32. PMID: 11560802.
        View in: PubMed
      84. Terdiman JP, Gum JR, Conrad PG, Miller GA, Weinberg V, Crawley SC, Levin TR, Reeves C, Schmitt A, Hepburn M, Sleisenger MH, Kim YS. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology. 2001 Jan; 120(1):21-30. PMID: 11208710.
        View in: PubMed
      85. Aust DE, Terdiman JP, Willenbucher RF, Chew K, Ferrell L, Florendo C, Molinaro-Clark A, Baretton GB, Löhrs U, Waldman FM. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Mod Pathol. 2001 Jan; 14(1):29-39. PMID: 11211307.
        View in: PubMed
      86. Terdiman JP. Genomic events in the adenoma to carcinoma sequence. Semin Gastrointest Dis. 2000 Oct; 11(4):194-206. PMID: 11057947.
        View in: PubMed
      87. Aust DE, Willenbucher RF, Terdiman JP, Ferrell LD, Chang CG, Moore DH, Molinaro-Clark A, Baretton GB, Loehrs U, Waldman FM. Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. Hum Pathol. 2000 Jan; 31(1):109-14. PMID: 10665921.
        View in: PubMed
      88. Terdiman JP, Conrad PG, Sleisenger MH. Genetic testing in hereditary colorectal cancer: indications and procedures. Am J Gastroenterol. 1999 Sep; 94(9):2344-56. PMID: 10483990.
        View in: PubMed
      89. Terdiman JP. Update on upper gastrointestinal bleeding. Basing treatment decisions on patients' risk level. Postgrad Med. 1998 Jun; 103(6):43-7, 51-2, 58-9 passim. PMID: 9633542.
        View in: PubMed
      90. Terdiman JP, Ostroff JW. Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med. 1998 Apr; 104(4):349-54. PMID: 9576408.
        View in: PubMed
      91. Terdiman JP, Ostroff JW. Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy. Am J Gastroenterol. 1997 Oct; 92(10):1805-11. PMID: 9382041.
        View in: PubMed
      92. Terdiman JP. The importance of accurate diagnosis and vigorous care of the patient with liver disease and gastrointestinal hemorrhage. Semin Gastrointest Dis. 1997 Oct; 8(4):166-78. PMID: 9360281.
        View in: PubMed
      93. Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW. The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation. Endoscopy. 1996 Oct; 28(8):680-5. PMID: 8934085.
        View in: PubMed
      Jonathan's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP